Interferon Alpha-2: Pre-Clinical and Clinical Evaluation: Proceedings of the Symposium held in Adjunction with the Second International Conference on ... 13, 1984: 27 (Developments in Oncology, 27) - Image 1

£77.81

Springer Interferon Alpha-2: Pre-Clinical and Clinical Evaluation: Proceedings of the Symposium held in Adjunction with the Second International Conference on ... 13, 1984: 27 (Developments in Oncology, 27)

Name: Interferon Alpha-2: Pre-Clinical and Clinical Evaluation: Proceedings of the Symposium held in Adjunction with the Second International Conference on ... 13, 1984: 27 (Developments in Oncology, 27)
Brand: Springer
Price: 77.81 GBP
Availability: InStock

Oncology

It has never been this cheap. We have no record of a lower price.

£78 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 62 days · 62 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 62 days • 1 price levels

Days at Price

Price Analysis

Most common price: £78 (62 days, 100.0%)

Price range: £78 - £78

Price levels: 1 different prices over 62 days

Description

Interferon alpha-2 is a genetically engineered, highly purified pharmaceutical agent that has undergone extensive phase I and phase II clinical study in more than 1000 patients. The material has biological activity by intravenous, intramus cular and subcutaneous routes. Clinical toxicity principally involves the 'influen za like' syndrome previously seen with native interferons. Other important toxi cities include anorexia, hepatitis, confusion and myelosuppression. Tolerable doses in multiple schedules and routes of administration have been determined. Phase II clinical trials with multiple routes and schedules of administration have been performed. Significant clinical activity has been found in non Hodgkin's lymphomas (both low grade and high grade), refractory and relapsing multiple myeloma, hairy cell leukemia, Kaposi's sarcoma, with suggestions of activity in Hodgkin's disease, renal cell carcinoma, and melanoma. The studies performed to date have for the most part involved small numbers of heavily pre-treated patients. Large-scale clinical trials in some of these disea ses are now warranted in populations of patients with as little bulk disease and prior treatment as is feasible for each tumour type. This is particularly the case in . Hodgkin's disease and subcategories of the non-Hodgkin's lymphomas. Alterna tely, interferon alpha-2 might be used to maintain remissions induced by other modalities (i. e. , in NHL, multiple myeloma, ovarian cancer). In some advanced disease settings, combinations of interferon alpha-2 with chemotherapeutic agents should now be investigated.

Product Specifications

Brand: Springer
Format: paperback
ASIN: 1461296188
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Publication Date: 05 October 2011
Listed Since: 21 December 2012

Barcode

No barcode data available

Springer Interferon Alpha-2: Pre-Clinical and Clinical Evaluation: Proceedings of the Symposium held in Adjunction with the Second International Conference on ... 13, 1984: 27 (Developments in Oncology, 27)

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Interferon Alpha-2: Pre-Clinical and Clinical Evaluation: Proceedings of the Symposium held in Adjunction with the Second International Conference on ... 13, 1984: 27 (Developments in Oncology, 27)

Interferon and Cancer

Nova Science Interferons: Mechanism and Clinical Applications

Viruses and Interferon: Current Research

Infections Related to Biologics, An Issue of Infectious Disease Clinics of North America: Volume 34-2 (The Clinics: Internal Medicine, Volume 34-2)

Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research)

Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research, 27)

Bacterial Activation of Type I Interferons

Novel Immunotherapeutic Approaches to Cancer Treatment - Springer

Novel Immunotherapeutic Approaches to Cancer Treatment - Springer

Immune Mediators in Cancer: Methods and Protocols: 2108 (Methods in Molecular Biology)

Infection and Cancer: Bi-Directorial Interactions

Burkitt Lymphoma: Updates in Etiology, Symptoms, Molecular Genetics and Treatment Options

OSH Infection in the Immunocompromised Host (Oxford Specialist Handbooks)

Tumor Immunology: Methods and Protocols: 1393 (Methods in Molecular Biology, 1393)

Negative Co-Receptors and Ligands: 350 (Current Topics in Microbiology and Immunology, 350)

IL-1 in Cancer and Inflammation - Academic Press Medical Book

Prognostic and Therapeutic Applications of RKIP in Cancer

Epstein-Barr Virus: Latency and Transformation

Infectious Agents Associated Cancers: Epidemiology and Molecular Biology: 1018 (Advances in Experimental Medicine and Biology, 1018)

Cancer Immunosurveillance: Methods and Protocols - Vol. 1884

Interferon and Nonviral Pathogens: Volume 42 Immunology

Immunoconjugate Therapy of Hematologic Malignancies: 68 (Cancer Treatment and Research, 68)

Advances in Cancer Research: 84: Volume 84